Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 25, 2013
Structures and interligand interaction pattern of phosphoramidite Pd complexes by NMR spectroscopy: modulations in extended interaction surfaces as stereoselection mode of a privileged class of ligandsEvelyn Hartmann, Michael M Hammer, Ruth M GschwindImmunological Reviews|January 6, 2009
Approaching the RNA ligand for RIG-I?Martin Schlee, Evelyn Hartmann, Christoph Coch, et al.Nature Chemistry|December 3, 2010
Highly diastereoselective Csp₃-Csp₂ Negishi cross-coupling with 1,2-, 1,3- and 1,4-substituted cycloalkylzinc compoundsTobias Thaler, Benjamin Haag, Andrei Gavryushin, et al.Circulation Research|April 16, 2011
Activation of endothelial toll-like receptor 3 impairs endothelial functionSebastian Zimmer, Martin Steinmetz, Tobias Asdonk, et al.Cancer Research|October 16, 2003
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancerEvelyn Hartmann, Barbara Wollenberg, Simon Rothenfusser, et al.Clinical and Vaccine Immunology : CVI|August 25, 2006
Analysis of plasmacytoid and myeloid dendritic cells in nasal epitheliumEvelyn Hartmann, Hendrik Graefe, Anne Hopert, et al.Immunology|January 14, 2010
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alphaIsabelle Bekeredjian-Ding, Meike Schäfer, Evelyn Hartmann, et al.Cancer Research|June 17, 2010
Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cellsKirsten Kübler, Nadine Gehrke, Soheila Riemann, et al.Journal of Leukocyte Biology|July 22, 2009
Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNAChristoph Coch, Nicolas Busch, Vera Wimmenauer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotidesBernd Jahrsdorfer, Lars Mühlenhoff, Sue E Blackwell, et al.Pageof 2